Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA)

INTRODUCTION: The current American College of Rheumatology and European League Against Rheumatism treatment recommendations advise tapering biological disease-modifying antirheumatic drug (bDMARD) therapy in patients with rheumatoid arthritis (RA) who achieve stable clinical remission while receivin...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, Paul, Burmester, Gerd R, Naredo, Esperanza, Zhou, Yijie, Hojnik, Maja, Conaghan, Philip G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855387/
https://www.ncbi.nlm.nih.gov/pubmed/29490959
http://dx.doi.org/10.1136/bmjopen-2017-019007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855387/
https://www.ncbi.nlm.nih.gov/pubmed/29490959
http://dx.doi.org/10.1136/bmjopen-2017-019007

Ejemplares similares